Literature DB >> 26878663

Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation.

A Badbaran1, B Fehse1, M Christopeit1, T Aranyossy1, F A Ayuk1, C Wolschke1, N Kröger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26878663     DOI： 10.1038/bmt.2016.14

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Digital PCR.

Authors:  B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis.

Authors:  Haefaa Alchalby; Anita Badbaran; Tatjana Zabelina; Guido Kobbe; Joachim Hahn; Daniel Wolff; Martin Bornhäuser; Christian Thiede; Herrad Baurmann; Wolfgang Bethge; York Hildebrandt; Ulrike Bacher; Boris Fehse; Axel R Zander; Nicolaus Kröger
Journal:  Blood       Date:  2010-05-20       Impact factor: 22.113

3.  Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysis.

Authors:  K Weber; U Mock; B Petrowitz; U Bartsch; B Fehse
Journal:  Gene Ther       Date:  2009-12-17       Impact factor: 5.250

4.  Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms.

Authors:  Amy V Jones; Daniel Ward; Matthew Lyon; William Leung; Alison Callaway; Andrew Chase; Carolyn L Dent; Helen E White; Hans G Drexler; Jyoti Nangalia; Chris Mattocks; Nicholas C P Cross
Journal:  Leuk Res       Date:  2014-11-29       Impact factor: 3.156

5.  Derivation of a new hematopoietic cell line with endothelial features from a patient with transformed myeloproliferative syndrome: a case report.

Authors:  W Fiedler; R P Henke; S Ergün; U Schumacher; U M Gehling; G Vohwinkel; N Kilic; D K Hossfeld
Journal:  Cancer       Date:  2000-01-15       Impact factor: 6.860

6.  Somatic mutations of calreticulin in myeloproliferative neoplasms.

Authors:  Thorsten Klampfl; Heinz Gisslinger; Ashot S Harutyunyan; Harini Nivarthi; Elisa Rumi; Jelena D Milosevic; Nicole C C Them; Tiina Berg; Bettina Gisslinger; Daniela Pietra; Doris Chen; Gregory I Vladimer; Klaudia Bagienski; Chiara Milanesi; Ilaria Carola Casetti; Emanuela Sant'Antonio; Virginia Ferretti; Chiara Elena; Fiorella Schischlik; Ciara Cleary; Melanie Six; Martin Schalling; Andreas Schönegger; Christoph Bock; Luca Malcovati; Cristiana Pascutto; Giulio Superti-Furga; Mario Cazzola; Robert Kralovics
Journal:  N Engl J Med       Date:  2013-12-10       Impact factor: 91.245

7.  Quantitation of targets for PCR by use of limiting dilution.

Authors:  P J Sykes; S H Neoh; M J Brisco; E Hughes; J Condon; A A Morley
Journal:  Biotechniques       Date:  1992-09       Impact factor: 1.993

8.  Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.

Authors:  H Alchalby; A Badbaran; O Bock; B Fehse; U Bacher; A R Zander; N Kröger
Journal:  Bone Marrow Transplant       Date:  2010-01-11       Impact factor: 5.483

9.  JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse.

Authors:  Thoralf Lange; Anja Edelmann; Udo Siebolts; Rainer Krahl; Claudia Nehring; Nadja Jäkel; Michael Cross; Jacqueline Maier; Dietger Niederwieser; Claudia Wickenhauser
Journal:  Haematologica       Date:  2013-01-08       Impact factor: 9.941

10.  Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

Authors:  J Nangalia; C E Massie; E J Baxter; F L Nice; G Gundem; D C Wedge; E Avezov; J Li; K Kollmann; D G Kent; A Aziz; A L Godfrey; J Hinton; I Martincorena; P Van Loo; A V Jones; P Guglielmelli; P Tarpey; H P Harding; J D Fitzpatrick; C T Goudie; C A Ortmann; S J Loughran; K Raine; D R Jones; A P Butler; J W Teague; S O'Meara; S McLaren; M Bianchi; Y Silber; D Dimitropoulou; D Bloxham; L Mudie; M Maddison; B Robinson; C Keohane; C Maclean; K Hill; K Orchard; S Tauro; M-Q Du; M Greaves; D Bowen; B J P Huntly; C N Harrison; N C P Cross; D Ron; A M Vannucchi; E Papaemmanuil; P J Campbell; A R Green
Journal:  N Engl J Med       Date:  2013-12-10       Impact factor: 91.245
View more
  7 in total

1.  Impact of molecular residual disease post allografting in myelofibrosis patients.

Authors:  C Wolschke; A Badbaran; T Zabelina; M Christopeit; F Ayuk; I Triviai; A Zander; H Alchalby; U Bacher; B Fehse; N Kröger
Journal:  Bone Marrow Transplant       Date:  2017-07-17       Impact factor: 5.483

2.  Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis.

Authors:  M Christopeit; A Badbaran; T Zabelina; G Zeck; B Fehse; F Ayuk; C Wolschke; N Kröger
Journal:  Bone Marrow Transplant       Date:  2016-05-23       Impact factor: 5.483

Review 3.  Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches.

Authors:  Karl Haslam; Stephen E Langabeer
Journal:  Biomed Res Int       Date:  2016-10-20       Impact factor: 3.411

Review 4.  Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.

Authors:  Nicoletta Coccaro; Giuseppina Tota; Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

5.  Digital PCR Panel for Sensitive Hematopoietic Chimerism Quantification after Allogeneic Stem Cell Transplantation.

Authors:  Tanja Stahl; Caroline Rothe; Manja U Böhme; Aloisa Kohl; Nicolaus Kröger; Boris Fehse
Journal:  Int J Mol Sci       Date:  2016-09-09       Impact factor: 5.923

Review 6.  Allogeneic hematopoietic stem-cell transplantation for myelofibrosis.

Authors:  Lining Zhang; Fan Yang; Sizhou Feng
Journal:  Ther Adv Hematol       Date:  2020-02-13

Review 7.  The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms.

Authors:  Tanja Belčič Mikič; Tadej Pajič; Samo Zver; Matjaž Sever
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.